Status:

COMPLETED

Reperfusion Therapy in Acute Ischemic Stroke With Unclear Onset

Lead Sponsor:

Asan Medical Center

Collaborating Sponsors:

Ministry of Health & Welfare, Korea

Conditions:

Stroke

Eligibility:

All Genders

18-85 years

Brief Summary

This study will test the hypothesis whether patients with unclear-onset stroke (UnCLOS) treated with thrombolysis could achieve a prespecified rate of good clinical outcome. The secondary hypothesis i...

Detailed Description

1. Study design: A prospective multicenter trial 2. Study centers: 6 participating medical centers in South Korea 3. Participants: Consecutive patients with acute ischemic stroke visiting the emergenc...

Eligibility Criteria

Inclusion

  • The patient is male or female and age between 18 and 85 years
  • The patient has unclear onset stroke
  • Treatment of the patient can be initiated within 6 hours after first found abnormal time
  • The patient has imaging-defined penumbra (at least 20%), measured by diffusion- and perfusion-weighted MRI

Exclusion

  • The patient has minor neurologic deficits (NIHSS \<4, except aphasia or hemianopia).
  • The patient has rapidly resolving neurological symptoms and the rate of improvement is projected to give the patient an NIHSS score \<4 at the time of treatment.
  • The patient has a pre-stroke mRS score of \>1 (indicating previous disability).
  • The symptoms of stroke are suggestive of subarachnoid hemorrhage.
  • Evidence of infective endocarditis or septic embolism
  • The patient has a history or clinical presentation of ICH, SAH, or AVM.
  • Serious head trauma within 6 weeks
  • Prior ischemic stroke in previous 6 weeks (except small infarct)
  • Myocardial infarction in the previous 3 weeks
  • Gastrointestinal or urinary tract bleeding in previous 21 days
  • Major surgery in the previous 14 days
  • History of biopsy of a parenchymal organ, trauma with internal organ injury or lumbar puncture within 14 days
  • Arterial puncture at a non-compressible site in the previous 7 days
  • Uncontrolled high blood pressure (systolic \> 185 mmHg or diastolic \> 110 mmHg on 3 separate occasions at least 10 min apart despite appropriate treatment)
  • Evidence of active bleeding or acute trauma (fracture) on examination
  • Current use of oral anticoagulants and a prolonged prothrombin time (INR \>1.7)
  • The patient has been treated with heparin in the previous 48 hours with prolonged aPTT, except for low dose subcutaneous LMWH with doses recommended for DVT prophylaxis
  • Baseline platelet count \< 100,000 mm3
  • Baseline hematocrit \< 25%
  • Blood glucose concentration \< 50 mg/dL (2.7 mmol/L) in case of CT screening
  • Seizure at onset with postictal residual neurological impairments in case of CT screening
  • The patient has a terminal illness.
  • The patient is, in the opinion of the investigator, unlikely to comply with the clinical study protocol or is unsuitable for any other reason.
  • The patient has extensive early infarction in any affected area defined as an infarcted core involving \> 1/3 of MCA territory or the entire ACA or PCA territory
  • The patient has well-developed parenchymal hyperintensity on FLAIR, T2\*, or EPI-T2 images, or marked hypodensity on CT, indicative of subacute infarction, or enhancement with morphologic features suggesting the lesion is more than 6 hours old
  • The patient has a contraindication to the imaging techniques (this means ferromagnetic objects for MRI, contraindications to contrast agent, renal disease with iodinated contrast agent in perfusion CT and CTA, etc.)
  • The patient has imaging evidence of ICH or SAH, AVM, brain tumor (Incidental meningioma and microbleeds are not exclusion criteria. Incidental unruptured aneurysm that is small (\< 5mm) is not an exclusion criterion).

Key Trial Info

Start Date :

October 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2009

Estimated Enrollment :

83 Patients enrolled

Trial Details

Trial ID

NCT01138059

Start Date

October 1 2006

End Date

June 1 2009

Last Update

June 7 2010

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.